Literature DB >> 16679473

Clinical outcome of patients with Helicobacter pylori infection: the bug, the host, or the environment?

S N Sgouros1, C Bergele.   

Abstract

It is well established that only a minority of patients with Helicobacter pylori infection develop severe inflammation leading to peptic ulcer or gastric cancer. Recent evidence suggests that the virulence factors of the organism do not seem crucial in the progression of inflammation towards a more severe disease. It seems probable that other host derived and environmental factors are more significant in determining clinical outcome but additional studies are needed to clarify the underlying mechanisms involved in the pathogenesis of infection.

Entities:  

Mesh:

Year:  2006        PMID: 16679473      PMCID: PMC2563779          DOI: 10.1136/pgmj.2005.038273

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  51 in total

Review 1.  Disease-specific Helicobacter pylori virulence factors: the unfulfilled promise.

Authors:  D Y Graham; Y Yamaoka
Journal:  Helicobacter       Date:  2000       Impact factor: 5.753

2.  Local pH elevation mediated by the intrabacterial urease of Helicobacter pylori cocultured with gastric cells.

Authors:  C Athmann; N Zeng; T Kang; E A Marcus; D R Scott; M Rektorschek; A Buhmann; K Melchers; G Sachs
Journal:  J Clin Invest       Date:  2000-08       Impact factor: 14.808

3.  Expression of the Helicobacter pylori ureI gene is required for acidic pH activation of cytoplasmic urease.

Authors:  D R Scott; E A Marcus; D L Weeks; A Lee; K Melchers; G Sachs
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

4.  Helicobacter pylori augments the acid inhibitory effect of omeprazole on parietal cells and gastric H(+)/K(+)-ATPase.

Authors:  W Beil; K F Sewing; R Busche; S Wagner
Journal:  Gut       Date:  2001-02       Impact factor: 23.059

5.  Interleukin-1 polymorphisms associated with increased risk of gastric cancer.

Authors:  E M El-Omar; M Carrington; W H Chow; K E McColl; J H Bream; H A Young; J Herrera; J Lissowska; C C Yuan; N Rothman; G Lanyon; M Martin; J F Fraumeni; C S Rabkin
Journal:  Nature       Date:  2000-03-23       Impact factor: 49.962

6.  Synergistic interaction between hypergastrinemia and Helicobacter infection in a mouse model of gastric cancer.

Authors:  T C Wang; C A Dangler; D Chen; J R Goldenring; T Koh; R Raychowdhury; R J Coffey; S Ito; A Varro; G J Dockray; J G Fox
Journal:  Gastroenterology       Date:  2000-01       Impact factor: 22.682

7.  Activation of activator protein 1 and stress response kinases in epithelial cells colonized by Helicobacter pylori encoding the cag pathogenicity island.

Authors:  M Naumann; S Wessler; C Bartsch; B Wieland; A Covacci; R Haas; T F Meyer
Journal:  J Biol Chem       Date:  1999-10-29       Impact factor: 5.157

8.  Acute gastritis with hypochlorhydria: report of 35 cases with long term follow up.

Authors:  W V Harford; C Barnett; E Lee; G Perez-Perez; M J Blaser; W L Peterson
Journal:  Gut       Date:  2000-10       Impact factor: 23.059

9.  Evaluation of the clinical relevance of the iceA1 gene in patients with Helicobacter pylori infection in Japan.

Authors:  D Nishiya; T Shimoyama; S Fukuda; T Yoshimura; M Tanaka; A Munakata
Journal:  Scand J Gastroenterol       Date:  2000-01       Impact factor: 2.423

10.  Inability of an isogenic urease-negative mutant stain of Helicobacter mustelae to colonize the ferret stomach.

Authors:  K A Andrutis; J G Fox; D B Schauer; R P Marini; J C Murphy; L Yan; J V Solnick
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

View more
  4 in total

1.  Characterization of Helicobacter pylori cagA and vacA genotypes among Alaskans and their correlation with clinical disease.

Authors:  Karen Miernyk; Julie Morris; Dana Bruden; Brian McMahon; Debby Hurlburt; Frank Sacco; Alan Parkinson; Thomas Hennessy; Michael Bruce
Journal:  J Clin Microbiol       Date:  2011-07-13       Impact factor: 5.948

Review 2.  Helicobacter pylori infection: host immune response, implications on gene expression and microRNAs.

Authors:  Aline Cristina Targa Cadamuro; Ana Flávia Teixeira Rossi; Nathália Maciel Maniezzo; Ana Elizabete Silva
Journal:  World J Gastroenterol       Date:  2014-02-14       Impact factor: 5.742

3.  Epidemiological aspects of gastric adenocarcinoma: are predictive diagnostics and targeted preventive measures possible?

Authors:  Krister Sjödahl; Jesper Lagergren
Journal:  EPMA J       Date:  2010-07-22       Impact factor: 6.543

4.  Network pharmacology-based strategy to investigate pharmacological mechanisms of Zuojinwan for treatment of gastritis.

Authors:  Guohua Yu; Wubin Wang; Xu Wang; Meng Xu; Lili Zhang; Lei Ding; Rui Guo; Yuanyuan Shi
Journal:  BMC Complement Altern Med       Date:  2018-11-01       Impact factor: 3.659

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.